Extracellular matrix and wound healing

Pathologie Biologie

Volumn 62, Issue 2, 2014, Pages 91-95

  Maquart, F X ^a,b   Monboisse, J C ^a,b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Collagen; Connective tissue glycoproteins; Elastin; Extracellular matrix; Glycosaminoglycans; Matrikines; Proteoglycans; Wound healing

Indexed keywords

COLLAGEN; ELASTIN; FIBRIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; INTEGRIN; MATRIKINE; PROTEOGLYCAN; SCLEROPROTEIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBRIN CLOT; HUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; WOUND HEALING; ANIMAL; BLOOD CLOTTING; CELL HYPOXIA; CONNECTIVE TISSUE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD COAGULATION; CELL HYPOXIA; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRIN; GLYCOSAMINOGLYCANS; HUMANS; INTEGRINS; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTEOGLYCANS; WOUND HEALING;

EID: 84898489175     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2014.02.007     Document Type: Article

References (63)

1. Reinkes J.M., Sorg H. Wound repair and regeneration. Eur Surg Res 2012, 49:35-43.
2. Clark R.A., Lanigan J.M., Della Pelle P., Mansean E., Dvorak H.F., Colvin R.B. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982, 9:269-276.
3. Jennewein C., Tran N., Paulus P., Ellinghans P., Eble J.A., Zacharowski K. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 2011, 17:568-573.
4. Ahmann K.A., Weinbaum J.S., Johnson S.L., Tranquillo R.T. Fibrin degradation products enhance vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro. Tissue Engin Part A 2010, 16:3261-3270.
5. Gray A.J., Bishop J.E., Reeves J.T., Mecham R.P., Laurent G.J. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Resp Cell Mol Biol 1995, 12:684-690.
6. Dvorak H.F., Harvey V.S., Estrella P., Brown L.F., Mc Donagh J., Dvorak A.M. Fibrin-containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987, 57:673-686.
7. Manuskiatti W., Maibach H.I. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol 1996, 35:539-544.
8. Frenkel J.S. The role of hyaluronan in wound healing. Int Wound J 2012, [doc:10.1111/j 1742-481X.2012.01057.x].
9. Chen W.Y.J., Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep Reg 1999, 7:79-89.
10. Prodicimi M., Bevilacqua C. Exogenous hyaluronic acid and wound healing: an up-dated vision. Panminerva Med 2012, 54:129-135.
11. Lo D.D., Zimmerman A.S., Nauta A., Longaker M.T., Lorenz H.P. Scarless fetal skin wound healing update. Birth Defects Res C Embryo Today 2012, 96:237-247.
12. Caskey R.C., Allukian M., Lind R.C., Herdrich B.J., Xu J., Radu A., et al. Lentiviral-mediated over expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair. Cell Tissue Res 2013, 351:117-125.
13. Ghazi K., Deng-Pichon U., Warnet J.M., Rat P. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS ONE 2012, 7:e48351.
14. David-Raoudi M., Tranchepain F., Deschevrel B., Vincent J.C., Bogdanowicz P., Boumediene K., et al. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Rep Reg 2008, 16:274-287.
15. Gao F., Liu Y., Yang C., Wang Y., Shi X., Wei G. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010, 29:107-116.
16. Peplow P.V. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thromb Haemostas 2005, 94:4-16.
17. Taylor K.R., Gallo R.L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006, 20:9-22.
18. Ortega N., L'Faquihi F.E., Plouët J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. Biol Cell 1998, 90:381-390.
19. Yamaguchi Y., Mann D.M., Ruoslathi E. Negative regulation of the transforming growth factor-ß by the proteoglycan decorin. Nature 1990, 346:281-284.
20. Zhou Z., Wang J., Cao R., Morita H., Soininen R., Chan K.M., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate deficient mice. Cancer Res 2004, 64:4699-4702.
21. Merrilees M.J., Lemire J.M., Fisher J.W., Kinsella M.G., Brana K.R., Clowees A.W., et al. Retrovirally-mediated overexpression of versican V3 by arterial smooth muscle cell induces tropoelastin synthesis and elastic fiber formation in vitro and in neo-intima after vascular injury. Circ Res 2002, 90:481-487.
22. Cattaruzza S., Perris R. Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol 2005, 24:400-417.
23. Hattori N., Carinno D.A., Lauer M.E., Vascinji A., Wylie J.D., Nelson C.M., et al. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J Biol Chem 2007, 39:505-528.
24. Elenius K., Vainio S., Laoto M., Salmivirta M., Thesleff I., Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol 1991, 114:585-595.
25. Stepp M.A., Gibson H.E., Gala P.H., Iglesia D.D., Pajookesh-Ganji A., Pal-Gosh S., et al. Defects in keratinocyte activation during wound healing in the syndecan-1- deficient mice. J Cell Sci 2002, 115:4517-4531.
26. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001, 107:R9-R14.
27. Lin F., Ren X.D., Doris G., Clark R.A. Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan -4 proteoglycan. J Invest Dermatol 2005, 124:906-913.
28. Murphy-Ullrich J.E., Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000, 11:59-69.
29. Kanayama M., Kurotaki D., Asano T., Matsui Y., Nakayama Y., Saito Y., et al. Alpha-9 integrin and its ligands contitute critical joint microenvironments for development of auto-immune arthritis. J Immunol 2009, 182:8015-8025.
30. Midwood K.S., Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009, 3:287-310.
31. Rodrigues M., Yates C.C., Nuschke A., Griffith L., Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 2013, 19:1972-1983.
32. Lenselink E.A. Role of fibronectin in normal wound healing. Int Wound J 2013, doi:10.1111/iwj.12109 [E-pub ahead of print].
33. Maquart F.X., Simeon A., Pasco S., Monboisse J.C. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J Soc Biol 1999, 193:423-428.
34. Mirastschijski U., Hasksma C.J., Tomasek J.J., Agren M.S. Matrix metalloproteinase inhibitor GM6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004, 229:465-475.
35. Carmeliet P., Moons L., Lijnen R., Janssens S., Lupu F., Collen D., et al. Inhibitory role of plasminogen activator inhibitor in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997, 96:3184-3191.
36. Maquart F.X., Cornillet-Stoupy J., Randoux A., Borel J.P. Inhibition of fibroblastic cell division by a fraction of structural glycoproteins extracted from rabbit dermis. Biochem Biophys Res Commun 1984, 125:509-515.
37. Laskin D.L., Kimura T., Sakakibara S., Riley D.J., Berg R.A. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol 1986, 39:255-266.
38. Maquart F.X., Pickart L., Laurent M., Gillery P., Monboisse J.C., Borel J.P. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988, 238:343-346.
39. Freedman J.H., Pickart L., Weinstein B., Mims W.B., Peisach J. Structure of the Glycyl-L. -Histidyl-L-Lysine-copper (II) complex in solution. Biochemistry 1982, 21:4540-4544.
40. Siméon A., Wegrowski Y., Bontemps Y., Maquart F.X. Expression of glycosaminoglycans and small proteoglycans in wounds. Modulation by the tripeptide-copper complex Glycyl-L-Histidyl-L-Lysine-Cu2+. J Invest Dermatol 2000, 115:962-968.
41. Maquart F.X., Bellon G., Chaqour B., Wegrowski Y., Patt L.M., Trachy R.E., et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest 1993, 92:2368-2376.
42. Choi H.R., Kang Y.A., Ryoo S.J., Skin J.W., Na J.I., Huh C.H., et al. Stem cell recovering effect of copper-free GHK in skin. J Pept Sci 2012, 18:685-690.
43. Katayama K., Armendariz-Borunda J., Rhagow R., Kang A.H., Seyer J.M. A pentapeptide from type I collagen promotes extracellular matrix production. J Biol Chem 1993, 268:9941-9944.
44. Farwick M., Grether-Beck, Marini A., Maczkiewitz U., Lange J., Köhler T., et al. Bioactive tetrapeptide GEKG boosts extracellular matrix formation: in vitro and in vivo molecular and clinical proof. Exp Dermatol 2011, 20:600-613.
45. Tsai W.C., Hsu C.C., Chung C.Y., Lin M.S., Li S.L., et al. The pentapeptide KTTKS promoting the expressions of type I collagen and transforming growth factor-ß of tendon cells. J Orthop Res 2007, 25:1629-1634.
46. Duca L., Floquet N., Alix A.J., Haye B., Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 2004, 49:235-244.
47. Robert L., Poullain N. Studies on the structure of elastin and the mode of action of elastase I. New method of preparation of soluble derivatives of elastin. Bull Soc Chim Biol (Paris) 1963, 45:1317-1326.
48. Jacob M.P., Fülop T., Foris G., Robert L. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci U S A 1987, 84:995-999.
49. Antonicelli F., Bellon G., Lorimier S., Hornebeck W. Role of the elastin receptor complex (S-Gal/Cath-A/Neu-1) in skin repair and regeneration. Wound Rep Reg 2009, 17:631-638.
50. Duca L., Blanchevoye C., Cantarelli B., Gonheim C., Dedieu S., Delacoux F., et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 submit. J Biol Chem 2007, 282:12484-12491.
51. Brassart B., Fuchs P., Huet E., Alix.A.J., Wallach J., Tamburso A.M., et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001, 276:5222-5227.
52. Kariya Y., Miyazaki K. The basement membrane protein laminin-5 acts as a soluble cell mobility factor. Exp cell Res 2004, 297:508-520.
53. Shang M., Koshikawa M., Schenk S., Quaranta V. The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading and migration. J Biol Chem 2001, 276:33045-33053.
54. Swindle C.S., Tran K.T., Johnson T.D., Banerjee P., Mayes A.M., Griffith L., et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF-receptor. J Cell Biol 2001, 154:459-468.
55. Adams E., Smith E.L. Peptidases of erythrocytes. II. Isolation and properties of prolidase. J Biol Chem 1952, 198:671-682.
56. Surazynski A., Donald S.P., Cooper S.K., Whyteside M.A., Salnikox E., Lin Y., et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 2008, 122:1435-1440.
57. Ahluwalia A., Tarnowsky A.S. Critical role of hypoxia sensor- HIF-1a in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012, 19:90-97.
58. Botusan I.R., Sunkary V.G., Savu O., Catrina A.I., Grünler J., Lindberg S., et al. Stabilization of HIF-1a is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008, 19426-19431.
59. Watt F.M. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002, 21:3919-3926.
60. Grose R., Hutter C., Bloch W., Thorey I., Watt F.M., Fässler R., et al. A crucial role of ß1-integrin for keratinocyte migration in vitro and during cutaneous wound repair. Development 2002, 129:2303-2315.
61. Reynolds L.E., Conti F.J., Silva R., Robinson S.D., Iyer V., et al. A3ß1 integrin-controlled Smad 7 regulates reepithelialization during wound healing in mice. J Clin Invest 2008, 118:965-974.
62. Senger D.R., Claffey K.P., Benes J.E., Peruzzi C.A., Sergiou A.P., Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A 1997, 94:13612-13617.
63. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alphavbeta3 for angiogenesis. Science 1994, 264:569-571.